Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Cancers|March 10, 2022
What Defines Quality of Life for Older Patients Diagnosed with Cancer? A Qualitative StudyPetronella A L Nelleke Seghers, Jolina A Kregting, Lieke H van Huis-Tanja, et al.Journal of Geriatric Oncology|May 22, 2014
Determinants of short- and long-term survival from colorectal cancer in very elderly patientsJuliette Sheridan, Paul Walsh, David Kevans, et al.BMJ Open|September 30, 2021
Observational study investigating Tolerance Of Anticancer Systemic Therapy In the Elderly (TOASTIE): a protocolHelen Dearden, Mark A Baxter, Sally Martin, et al.BMC Health Services Research|December 14, 2019
What are the mechanisms that support healthcare professionals to adopt assisted decision-making practice? A rapid realist reviewCarmel Davies, Francesco Fattori, Deirdre O'Donnell, et al.BMJ Open Quality|March 28, 2020
Testicular cancer: improving outcomes with national quality performance indicatorsMark A Baxter, Graham MacDonald, Jahangeer Malik, et al.British Journal of Cancer|February 2, 2021
The impact of COVID-19 on systemic anticancer treatment delivery in ScotlandMark A Baxter, John Murphy, David Cameron, et al.Cancers|May 13, 2023
Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma-A Post-hoc Analysis of the GO2 TrialMark A Baxter, Lindsay C Spender, Shaun Walsh, et al.The British Journal of Surgery|February 22, 2023
Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national studyMark A Baxter, Khurram S Khan, Lewis S Gall, et al.Global Health Research and Policy|August 31, 2023
Geriatric assessment for older people with cancer: policy recommendationsP A L Seghers, Shabbir M H Alibhai, Nicolò Matteo Luca Battisti, et al.Journal of Geriatric Oncology|April 6, 2024
Study protocol for two stepped-wedge interventional trials evaluating the effects of holistic information technology-based patient-oriented management in older multimorbid patients with cancer: The GERONTE trialsMarije E Hamaker, Hans Wildiers, Vittoria Ardito, et al.Pageof 6